Kindstar to Offer Insight Genetics' ALK Lung Cancer Screening Test | GenomeWeb

NEW YORK (GenomeWeb News) – Insight Genetics and Kindstar Globalgene Technology announced Thursday evening a licensing deal for the Insight ALK Screen lung cancer test.

Under the terms, Insight ALK Screen will be added to Kindstar's menu of tests directed at cancer diagnosis and care offered in China and surrounding areas. Kindstar anticipates offering Insight ALK Screen in China, Hong Kong, and Macau starting next month.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.